Published in Transplant Proc on March 01, 1979
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med (1983) 4.92
Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation. Proc Natl Acad Sci U S A (1982) 1.87
Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain. Clin Exp Immunol (1986) 1.70
Depletion of epidermal langerhans cells and Ia immunogenicity from tape-stripped mouse skin. J Exp Med (1982) 1.06
The surface properties and antigen-presenting function of hepatic non-parenchymal cells. Clin Exp Immunol (1981) 0.98
Postpartum immunologic-mediated pulmonary edema associated with transfusion of blood containing an anti-B-lymphocyte antibody. West J Med (1989) 0.79
Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med (1989) 4.30
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 2.72
HLA-D restriction of the macrophage-dependent response of immune human T lymphocytes to PPD in vitro: inhibition by anti-HLA-DR antisera. Scand J Immunol (1978) 2.70
HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet (1999) 2.17
Studies on human epidermal Langerhans cells. I. Allo-activating and antigen-presenting capacity. Scand J Immunol (1980) 2.09
[Treatment of spinal cord compression caused by malignant disease]. Tidsskr Nor Laegeforen (1991) 2.04
[Genetic diagnostic test for hemochromatosis]. Tidsskr Nor Laegeforen (1998) 2.02
HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum (1980) 1.97
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol (1998) 1.85
Macrophage-dependent response of immune human T lymphocytes to PPD in vitro. Influence of HLA-D histocompatibility. Scand J Immunol (1977) 1.84
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature (1976) 1.82
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens (2007) 1.77
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. Tissue Antigens (1986) 1.67
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun (2004) 1.53
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol Rev (1982) 1.51
The human mixed lymphocyte-endothelium culture interaction. Transplantation (1975) 1.50
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45
Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. Scand J Gastroenterol (1978) 1.43
Antigen-presenting properties of human vascular endothelial cells. J Exp Med (1980) 1.43
HLA-D region molecules restrict proliferative T cell responses to antigen. Immunol Rev (1982) 1.42
The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region. J Exp Med (1977) 1.38
Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. J Immunol Methods (1986) 1.38
T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. Hum Immunol (1994) 1.37
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
The role of macrophages in the lymphoproliferative response to Mycobacterium leprae in vitro. Clin Exp Immunol (1978) 1.33
Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand J Immunol (1987) 1.33
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
Lack of cell-mediated cytotoxicity towards Chlamydia trachomatis infected target cells in humans. Acta Pathol Microbiol Immunol Scand C (1984) 1.32
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet (1997) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens (1993) 1.31
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol (1997) 1.29
Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27
The human major histocompatibility system. Transplant Rev (1974) 1.25
Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol (1988) 1.24
A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens (1999) 1.22
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes (1997) 1.22
HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. Tissue Antigens (1971) 1.22
Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol (1996) 1.22
Specific destruction of human endothelial cell monolayers by anti-DRw antisera. Transplantation (1979) 1.21
Conservation genomics of Atlantic salmon: SNPs associated with QTLs for adaptive traits in parr from four trans-Atlantic backcrosses. Heredity (Edinb) (2008) 1.21
The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis (1983) 1.21
BAC-based upgrading and physical integration of a genetic SNP map in Atlantic salmon. Anim Genet (2009) 1.20
Cell specific and common antigens on human granulocytes and lymphocytes demonstrated with cytotoxic hetero-antibodies. Vox Sang (1967) 1.19
Proliferative human T cell responses to Chlamydia trachomatis in vitro. Acta Pathol Microbiol Immunol Scand C (1983) 1.19
Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun (2003) 1.19
HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol (1992) 1.17
Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. Gastroenterology (1997) 1.17
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet (1995) 1.17
Rga (Rodgers) and the HLA region: linkage and associations. Tissue Antigens (1976) 1.16
Growth of precultured human glioma specimens in nude rat brain. J Neurosurg (1999) 1.15
Expression of major histocompatibility complex class II subregion products by jejunal epithelium in patients with coeliac disease. Scand J Immunol (1987) 1.15
HLA DR antigens and gold toxicity. Ann Rheum Dis (1983) 1.14
Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol (1990) 1.12
Metal working fluid-associated hypersensitivity pneumonitis: an outbreak investigation and case-control study. Am J Ind Med (1999) 1.11
Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens (1991) 1.11
Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens (1997) 1.11
Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol (1981) 1.10
Cell mediated lympholysis: CML. a microplate technique requiring few target cells and employing a new method of supernatant collection. J Immunol Methods (1977) 1.10
T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr (1989) 1.09
Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. Acta Derm Venereol (1980) 1.09
The development and characterization of a 57K single nucleotide polymorphism array for rainbow trout. Mol Ecol Resour (2014) 1.08
The Bf locus in the HLA region of chromosome 6: linkage and association studies. Humangenetik (1975) 1.07
T cells from the peripheral blood of coeliac disease patients recognize gluten antigens when presented by HLA-DR, -DQ, or -DP molecules. Scand J Immunol (1994) 1.07
HLA-DRw4 and rheumatoid arthritis. Lancet (1979) 1.06
Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol (1997) 1.06
HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum (1983) 1.05
HLA-D region products are expressed in endothelial cells. Tissue Antigens (1980) 1.03
Polymorphism of the HL-A system. Transplant Proc (1971) 1.03
HLA antigens on glioma cells from short term cultures. Tissue Antigens (1982) 1.02
Presentation of viral antigens by human vascular endothelial cells in vitro. Hum Immunol (1981) 1.02
Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics (1996) 1.02
In vitro sensitization of human T lymphocytes to hapten (TNP)-conjugated and non-treated autologous cells is restricted by self-HLA-D. Scand J Immunol (1979) 1.02
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens (1990) 1.01
Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. Am J Hum Genet (1998) 1.01
Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. Hum Mol Genet (1997) 1.01
Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6). Hum Mol Genet (1998) 1.01
Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells. J Virol Methods (1989) 1.01
Further evidence of a third HL-A locus. Tissue Antigens (1973) 1.00
Activation of human suppressor cells in mixed lymphocyte cultures. Scand J Immunol (1977) 1.00
C3 polymorphism: genetic linkage relations. Clin Genet (1974) 1.00
HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet (2001) 1.00
The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum Immunol (1989) 0.99
HLA-D-restricted antigen activation of sensitized T lymphocytes: studies on the ability of HLA-D/DR-expressing B lymphocytes to substitute for macrophages in antigen activation. Scand J Immunol (1979) 0.99
On the orientation of the HL-A region and the PGM3 locus in the chromosome. Tissue Antigens (1972) 0.99